These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12871497)

  • 1. Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus.
    De Cristofaro R; Rocca B; Vitacolonna E; Falco A; Marchesani P; Ciabattoni G; Landolfi R; Patrono C; Davì G
    J Thromb Haemost; 2003 Feb; 1(2):250-6. PubMed ID: 12871497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.
    Davì G; Ciabattoni G; Consoli A; Mezzetti A; Falco A; Santarone S; Pennese E; Vitacolonna E; Bucciarelli T; Costantini F; Capani F; Patrono C
    Circulation; 1999 Jan; 99(2):224-9. PubMed ID: 9892587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.
    Davì G; Chiarelli F; Santilli F; Pomilio M; Vigneri S; Falco A; Basili S; Ciabattoni G; Patrono C
    Circulation; 2003 Jul; 107(25):3199-203. PubMed ID: 12810609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
    J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease.
    Minuz P; Patrignani P; Gaino S; Degan M; Menapace L; Tommasoli R; Seta F; Capone ML; Tacconelli S; Palatresi S; Bencini C; Del Vecchio C; Mansueto G; Arosio E; Santonastaso CL; Lechi A; Morganti A; Patrono C
    Circulation; 2002 Nov; 106(22):2800-5. PubMed ID: 12451006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of platelet activation in human essential hypertension.
    Minuz P; Patrignani P; Gaino S; Seta F; Capone ML; Tacconelli S; Degan M; Faccini G; Fornasiero A; Talamini G; Tommasoli R; Arosio E; Santonastaso CL; Lechi A; Patrono C
    Hypertension; 2004 Jan; 43(1):64-70. PubMed ID: 14656953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss.
    Simeone P; Liani R; Tripaldi R; Di Castelnuovo A; Guagnano MT; Tartaro A; Bonadonna RC; Federico V; Cipollone F; Consoli A; Santilli F
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activation in obese women: role of inflammation and oxidant stress.
    Davì G; Guagnano MT; Ciabattoni G; Basili S; Falco A; Marinopiccoli M; Nutini M; Sensi S; Patrono C
    JAMA; 2002 Oct 23-30; 288(16):2008-14. PubMed ID: 12387653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus.
    Santilli F; Formoso G; Sbraccia P; Averna M; Miccoli R; Di Fulvio P; Ganci A; Pulizzi N; Lattanzio S; Ciabattoni G; Consoli A; Lauro R; Patrono C; Davì G
    J Thromb Haemost; 2010 Apr; 8(4):828-37. PubMed ID: 20088941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype.
    Vazzana N; Ganci A; Cefalù AB; Lattanzio S; Noto D; Santoro N; Saggini R; Puccetti L; Averna M; Davì G
    J Am Heart Assoc; 2013 Apr; 2(2):e000063. PubMed ID: 23557750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies.
    Martinuzzo ME; Forastiero RR; Kordich L; Carreras LO
    Br J Haematol; 2001 Sep; 114(4):845-51. PubMed ID: 11564073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidant stress as a major determinant of platelet activation in invasive breast cancer.
    Ferroni P; Santilli F; Cavaliere F; Simeone P; Costarelli L; Liani R; Tripaldi R; Riondino S; Roselli M; Davi G; Guadagni F
    Int J Cancer; 2017 Feb; 140(3):696-704. PubMed ID: 27784132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation.
    Davì G; Neri M; Falco A; Festi D; Taraborelli T; Ciabattoni G; Basili S; Cuccurullo F; Patrono C
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):246-51. PubMed ID: 15472127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients.
    Véricel E; Colas R; Calzada C; Lê QH; Feugier N; Cugnet C; Vidal H; Laville M; Moulin P; Lagarde M
    Thromb Haemost; 2015 Aug; 114(2):289-96. PubMed ID: 25832443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease.
    Vazzana N; Santilli F; Lattanzio S; Liani M; Giacci L; Del Rosso G; Salvati F; Boccatonda A; Ferroni P; Davì G
    Eur J Intern Med; 2016 Sep; 33():74-80. PubMed ID: 27389698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo lipid peroxidation and platelet activation in cystic fibrosis.
    Ciabattoni G; Davì G; Collura M; Iapichino L; Pardo F; Ganci A; Romagnoli R; Maclouf J; Patrono C
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1195-201. PubMed ID: 11029317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and platelet activation in homozygous homocystinuria.
    Davì G; Di Minno G; Coppola A; Andria G; Cerbone AM; Madonna P; Tufano A; Falco A; Marchesani P; Ciabattoni G; Patrono C
    Circulation; 2001 Sep; 104(10):1124-8. PubMed ID: 11535567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of platelet activation in hypertensives with microalbuminuria.
    Guagnano MT; Ferroni P; Santilli F; Paoletti V; Manigrasso MR; Pescara L; Cuccurullo C; Ciabattoni G; Davì G
    Free Radic Biol Med; 2009 Apr; 46(7):922-7. PubMed ID: 19280705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers.
    Patrignani P; Panara MR; Tacconelli S; Seta F; Bucciarelli T; Ciabattoni G; Alessandrini P; Mezzetti A; Santini G; Sciulli MG; Cipollone F; Davì G; Gallina P; Bon GB; Patrono C
    Circulation; 2000 Aug; 102(5):539-45. PubMed ID: 10920066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of vitamin C on the relationship among inflammation, lipid peroxidation and platelet activation during analgesic nephropathy in rats.
    Hadzi-Petrushev N; Mitrov D; Kostovski V; Mladenov M
    J Basic Clin Physiol Pharmacol; 2017 Sep; 28(5):473-481. PubMed ID: 28771433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.